181 related articles for article (PubMed ID: 28583160)
1. Differential expression of Cathepsin E in transthyretin amyloidosis: from neuropathology to the immune system.
Gonçalves NP; Moreira J; Martins D; Vieira P; Obici L; Merlini G; Saraiva M; Saraiva MJ
J Neuroinflammation; 2017 Jun; 14(1):115. PubMed ID: 28583160
[TBL] [Abstract][Full Text] [Related]
2. Schwann cells contribute to neurodegeneration in transthyretin amyloidosis.
Murakami T; Sango K; Watabe K; Niimi N; Takaku S; Li Z; Yamamura K; Sunada Y
J Neurochem; 2015 Jul; 134(1):66-74. PubMed ID: 25693163
[TBL] [Abstract][Full Text] [Related]
3. MMP-14 overexpression correlates with the neurodegenerative process in familial amyloidotic polyneuropathy.
Martins D; Moreira J; Gonçalves NP; Saraiva MJ
Dis Model Mech; 2017 Oct; 10(10):1253-1260. PubMed ID: 28993312
[TBL] [Abstract][Full Text] [Related]
4. The inflammatory response to sciatic nerve injury in a familial amyloidotic polyneuropathy mouse model.
Gonçalves NP; Teixeira-Coelho M; Saraiva MJ
Exp Neurol; 2014 Jul; 257():76-87. PubMed ID: 24800914
[TBL] [Abstract][Full Text] [Related]
5. Sensory nerve degeneration in a mouse model mimicking early manifestations of familial amyloid polyneuropathy due to transthyretin Ala97Ser.
Kan HW; Chiang H; Lin WM; Yu IS; Lin SW; Hsieh ST
Neuropathol Appl Neurobiol; 2018 Dec; 44(7):673-686. PubMed ID: 29423915
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "in vivo" evidence from FAP mice models.
Ferreira N; Saraiva MJ; Almeida MR
PLoS One; 2012; 7(1):e29933. PubMed ID: 22253829
[TBL] [Abstract][Full Text] [Related]
7. Clusterin overexpression and its possible protective role in transthyretin deposition in familial amyloidotic polyneuropathy.
Magalhães J; Saraiva MJ
J Neuropathol Exp Neurol; 2011 Dec; 70(12):1097-106. PubMed ID: 22082661
[TBL] [Abstract][Full Text] [Related]
8. Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling.
Sousa MM; Saraiva MJ
Prog Neurobiol; 2003 Dec; 71(5):385-400. PubMed ID: 14757117
[TBL] [Abstract][Full Text] [Related]
9. The Expression of Chemokines Is Downregulated in a Pre-Clinical Model of TTR V30M Amyloidosis.
Moreira J; Costelha S; Saraiva M; Saraiva MJ
Front Immunol; 2021; 12():650269. PubMed ID: 34093538
[TBL] [Abstract][Full Text] [Related]
10. Protective role of anakinra against transthyretin-mediated axonal loss and cell death in a mouse model of familial amyloidotic polyneuropathy.
Gonçalves NP; Teixeira-Coelho M; Saraiva MJ
J Neuropathol Exp Neurol; 2015 Mar; 74(3):203-17. PubMed ID: 25668561
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation.
Murakami T; Nishimura H; Nagai T; Hemmi S; Kutoku Y; Ohsawa Y; Sunada Y
J Neurol Sci; 2017 Oct; 381():55-58. PubMed ID: 28991715
[TBL] [Abstract][Full Text] [Related]
12. Novel Antibody for the Treatment of Transthyretin Amyloidosis.
Hosoi A; Su Y; Torikai M; Jono H; Ishikawa D; Soejima K; Higuchi H; Guo J; Ueda M; Suenaga G; Motokawa H; Ikeda T; Senju S; Nakashima T; Ando Y
J Biol Chem; 2016 Nov; 291(48):25096-25105. PubMed ID: 27758856
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 signaling pathway as a therapeutic target in transthyretin amyloidosis.
Gonçalves NP; Vieira P; Saraiva MJ
Amyloid; 2014 Sep; 21(3):175-84. PubMed ID: 24918964
[TBL] [Abstract][Full Text] [Related]
14. Transthyretin is not expressed by dorsal root ganglia cells.
Sousa MM; Saraiva MJ
Exp Neurol; 2008 Dec; 214(2):362-5. PubMed ID: 18835560
[TBL] [Abstract][Full Text] [Related]
15. Activation of ERK1/2 MAP kinases in familial amyloidotic polyneuropathy.
Monteiro FA; Sousa MM; Cardoso I; do Amaral JB; Guimarães A; Saraiva MJ
J Neurochem; 2006 Apr; 97(1):151-61. PubMed ID: 16515552
[TBL] [Abstract][Full Text] [Related]
16. Extracellular matrix markers for disease progression and follow-up of therapies in familial amyloid polyneuropathy V30M TTR-related.
Cardoso I; Brito M; Saraiva MJ
Dis Markers; 2008; 25(1):37-47. PubMed ID: 18776590
[TBL] [Abstract][Full Text] [Related]
17. Downregulated Cathepsin E expression in bone marrow-derived macrophages from the pre-clinical familial amyloid polyneuropathy model.
Moreira J; Saraiva M; Saraiva MJ
Amyloid; 2019; 26(sup1):63-64. PubMed ID: 31343320
[No Abstract] [Full Text] [Related]
18. Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
Berg I; Thor S; Hammarström P
Neurodegener Dis; 2009; 6(3):127-38. PubMed ID: 19372706
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy.
Ebenezer GJ; Liu Y; Judge DP; Cunningham K; Truelove S; Carter ND; Sebastian B; Byrnes K; Polydefkis M
Ann Neurol; 2017 Jul; 82(1):44-56. PubMed ID: 28598015
[TBL] [Abstract][Full Text] [Related]
20. Familial amyloidotic polyneuropathy and transthyretin.
Nagasaka T
Subcell Biochem; 2012; 65():565-607. PubMed ID: 23225017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
